References
- Paik J., Blaner W.S., Sommer K.M., Moe R., Swisshelm K. Retinoids, retinoic acid receptors and breast cancer. Cancer Investig. 2002
- Widschwendter M., Berger J., Daxenbichler G., Muller-Holzer E., Widschwendter A., Mayr A., Marth C., Zeimet A.G. Loss of retinoic acid receptor beta expression in breast cancer and morphologically normal adjacent tissue but not in the normal tissue distant from the cancer. Cancer Res. 1997; 57: 4158–4161
- Xu X.C., Sneige N., Liu X., Nandagiri R., Lee J.J., Lukmanji F., Hortobagyi G., Lippman S.M., Dhingra K., Lotan R. Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis. Cancer Res. 1997; 57: 4992–4996
- Shao Z.M., Sheikh M.S., Chen J-C., Kute T., Aisner S., Schnapper L., Fontana J.A. Expression of the retinoic acid nuclear receptors (RARs) and retinoid X receptor (RXR) in estrogen receptor positive and negative breast cancer. Int. J. Oncol. 1994; 4: 859–863
- Roman S.D., Ormandy C.J., Manning D.L., Blamey R.W., Nicholson R.I., Sutherland R.L., Clarke C.L. Estradiol induction of retinoic acid receptors in human breast cancer cells. Cancer Res. 1993; 53: 5940–5945
- Li Y., Lee M.O., Wang H.G., Li Y., Hashimoto Y., Klaus M., Reed J.C., Zhang X. Retinoic acid receptor beta mediates the growth inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol. Cell Biol. 1996; 16: 1138–1149
- Takatsuka J., Takahashi N., de Luca L.M. Retinoic acid metabolism and inhibition of cell proliferation: an unexpected liaison. Cancer Res. 1996; 56: 675–678
- Houle B., Rochette-Egly C., Bradley W.E.C. Tumor-suppressive effect of the retinoic acid receptor β in human epidermoid lung cancer cells. Proc. Natl Acad. Sci. USA 1993; 90: 985–989
- Li X.-S., Shao Z.-M., Sheikh M.S., Eiseman J.L., Sentz D., Jetten A.M., Chen J-C., Dawson M.I., Aisner S., Rishi A.K., Guterrez P., Schnapper L., Fontana J.A. Retinoic acid nuclear receptor β (RARβ) inhibits breast carcinoma anchorage independent growth. J. Cell Physiol. 1995; 165: 449–458
- Widschwendter M., Berger J., Hermann M., Muller H.M., Amberger A., Zeschnigk M., Widschwendter A., Abendstein B., Zeimet A.G., Daxenbichler G., Marth C. Methylation and silencing of the retinoic acid receptor-beta2 gene in breast cancer. J. Natl Cancer Inst. 2000; 92(10)826–832
- Yang Q., Sakurai T., Yoshimura G., Mori I., Nakamura M., Nakamura Y., Suzuma T., Tamaki T., Umemura T., Kakudo K. Hypermethylation does not account for the frequent loss of the retinoic acid receptor beta2 in breast carcinoma. Anticancer Res. 2001; 21((3B))1829–1833
- Lee J.S., Newman R.A., Lippman S.M., Huber M.H., Minor T., Raber M.N., Krafoff I.H., Hong W.K. Phase I evaluation of all-trans-retinoic acid in adults with solid tumors. J. Clin. Oncol. 1993; 11: 959–966
- Veronesi U., De Palo G., Marubini E., Costa A., Formelli F., Mariani L., Decensi A., Camerini T., Del Turco M.R., Di Mauro M.G., Muraca M.G., Del Vecchio M., Pinto C., D'Aiuto G., Boni C., Campa T., Magni A., Miceli R., Perloff M., Malone W.F., Sporn M.B. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer. J. Natl Cancer Inst. 1999; 21: 1847–1856
- Budd G.T., Adamson P.C., Gupta M., Homayoun P., Sandstrom S.K., Murphy R.F., McLain D., Tuason L., Peereboom D., Bukowski R.M., Ganapathi R. Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer. Clin. Cancer Res. 1998; 4: 635–642
- Conley, B.A.; Egorin, M.J.; Sridhara, R.; Finley, R.; Hemady, R.; Wu, S.; Tait, N.S.; Van Echo, D.A. Phase I clinical trial of all trans-retinoic acid with correlation of its pharmacokinetics and pharmacodynamics.
- Bovenzi V., Momparler R.L. Antineoplastic action of 5-aza-2-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells. Cancer Chemother. Pharmacol. 2001; 48: 71–76
- Pili R., Kruszewski M.P., Hager B.W., Lantz J., Carducci M.A. Combination of phenylbutrate and 13-cis-retinoic acid inhibits prostate tumor growth and angio genesis. Cancer Res. 2001; 61: 1477–1485
- Ferrara F.F., Fazi F., Bianchini A., Padula F., Gelmetti V., Minucci S., Mancini M., Pelicci G., Lo Coco F., Nervi C. Histone deacetylase targeted treatment restores retinoic acid signalling and differentiation in acute myeloid leukemia. Blood 2001; 61: 2–7